Skip to main content

Together for ALS is developed and funded by Amylyx Pharmaceuticals EMEA B.V.

ALS: A disorder with a devastating physical and psychological impact

The impact of Amyotrophic Lateral Sclerosis (ALS) is felt around the world by people living with the disorder and their loved ones.

Diagnosis icon

Many people diagnosed with ALS in Europe have had a long and difficult road to diagnosis: 

the majority spend approximately one-third of their disease course searching for a diagnosis.

Life expectancy icon

Sadly, the average life expectancy from symptom onset is two to five years. 

Each year, a similar number of people die from ALS as are newly diagnosed.

Approved therapy icon

There is only one approved therapy for the treatment of ALS 

in the European Union, and there have been no new therapies approved in more than 25 years.

People living with ALS face rapid and relentless loss of physical functions, including deteriorating muscle function, loss of ability to move, speak and breathe unaided and eventually, death.

This loss of independence has a devastating emotional impact, not only on those living with the disorder but also their loved ones. In surveys conducted in four European countries, around a third of people living with ALS reported that they experience moderate or severe depression, while nearly half of caregivers showed signs of probable psychological distress.

Together for ALS began as a way to share the experiences of people living with ALS and their loved ones. Supported by patient advocacy groups across Europe, including Stichting ALS in The Netherlands, ARSLA in France, Fundación Luzón in Spain and EUpALS (European Organization for Professionals and Patients with ALS), partnered with Amylyx.

Together for ALS is continuing to collect stories to raise awareness, share the devastating consequences that people living with ALS and their loved ones face, and inspire others to feel empowered to share their stories as well.

ARSLA logo
Stichting ALS Netherlands logo
Fundación Luzón of Spain Logo
EUpALS logo

How could you participate in the campaign?

  • #1

    If you or someone you know is living with ALS and you would like to share your story, contact your local patient advocacy group or EUpALS

  • #2

    If you are a patient advocacy group and would like to get involved, contact us via email using info@amylyx.com

Hear personal stories from the ALS community*

Stories from Spain

Elsa and Eva

Elsa and Eva

Eva shares her experience as a mother of two children, Elsa and Mario, who have both been diagnosed with ALS, and the importance of living day to day.

Luis and Rosa

Luis and Rosa

Luis and Rosa reflect on the shock of Luis being diagnosed with ALS and how his experience as a nurse enabled him to see an ALS specialist quickly.

Miguel and Raquel

Miguel and Raquel

Miguel and Raquel discuss the physical impact that ALS has on the body and the similarity of Miguel’s symptoms to his mother’s, who was also diagnosed with ALS.

Luis and Sara

Luis and Sara

Luis and Sara describe the difficulty in receiving Luis’ diagnosis of ALS and how anger and frustration have given way to acceptance and adaptation.

Stories from the Netherlands

ALS is diagnosed, now what?

ALS is diagnosed, now what?

Learn about the emotional impact of an ALS diagnosis.

Impact on those around you

Impact on those around you

Hear how ALS can affect the friends and families of those living with the disorder.

Impact of symptoms on daily life

Impact of symptoms on daily life

Listen to different experiences of how ALS can affect daily life.

Staying positive

Staying positive

Understand the importance of focusing on positivity and treasuring memories following an ALS diagnosis.

Stories from France

Katherine's story

Katherine

Katherine describes the shock and confusion she felt when she was diagnosed with ALS.

Christophe's story

Christophe

Christophe sheds light on how the physical effects of ALS have impacted his mental well-being.

Dominique's story

Dominique

Dominique reflects on his frustration at being unable to complete simple tasks.

Maxime & Stephanie's story

Maxime & Stephanie

Maxime and Stephanie share their experience of Maxime being diagnosed with ALS at a young age.

*Some people featured here have passed away since sharing their stories. This serves as a memorial to them, and recognition for those still with us.

Amylyx’s commitment

Amylyx is committed to supporting and creating more moments for the neurodegenerative community through the discovery and development of innovative new treatments.

It is our mission to end the suffering caused by neurodegenerative diseases. Every day we strive for better therapies. We question the unquestioned, always in search of new solutions.

Our science is our humanity. From the individual neuron to the entire neurodegenerative disease community, we strive to enhance our knowledge, identify research opportunities, and grow our relationships to improve the lives of people with neurodegenerative diseases and of their families.

Founded in the U.S. nearly 10 years ago, we now have a presence in ten countries including the U.S., Canada and across Europe.

Together for ALS Hashtag

Together for ALS logo

We are proud to work with and support the ALS community

We are in this together.

#TogetherForALS